MedTrace Logo

Bioavailability Study of Leflunomide Tablets Under Fasting Conditions

NCT00652665 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 52

Last updated 2008-04-04

No results posted yet for this study

Summary

To compare the single-dose Bioavailability of Kali and Aventis

Conditions

  • To Determine the Bioequivalence Study Under Fasting

Interventions

DRUG

Leflunomide

Tablets, 20mg, single-dose

DRUG

ARAVA

Tablets, 20mg,single-dose

Sponsors & Collaborators

  • Novum Pharmaceutical Research Services

    collaborator INDUSTRY

  • Par Pharmaceutical, Inc.

    lead INDUSTRY

Principal Investigators

  • So Ran Hong · Novum Pharmaceutical Research Services

Study Design

Allocation
RANDOMIZED
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2003-06-30
Primary Completion
2003-07-31
Completion
2003-07-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00652665 on ClinicalTrials.gov